 | Up a level |
2016
Heimbach, A., Hauke, J., Richters, L., Kroeber, S., Altmueller, J., Becker, C., Thiele, H., Nuernberg, P., Bluemcke, B., Neidhardt, G., Riehm, K., Schmutzler, R. and Hahnen, E. (2016). TruRisk (R) based next-generation sequencing reveals a high prevalence of deleterious ATM mutations in BRCA1/2-negative breast and ovarian cancer families. Oncol. Res. Treat., 39. S. 52 - 53. BASEL: KARGER. ISSN 2296-5262
2015
Colagrossi, L., Salpini, R., Surdo, M., Battisti, A., Pollicita, M., Bertoli, A., Di Santo, F., Becker, C., Mastroianni, C., Marignani, M., Maylin, S., Delaugerre, C., Morisco, F., Coppola, N., Marrone, A., Sarmati, L., Andreoni, M., Angelico, M., Verheyen, J., Perno, C. F. and Svicher, V. (2015). A HYPER-GLYCOSYLATION OF HBV SURFACE MAJOR HYDROPHILIC REGION CORRELATES WITH IMMUNOSUPPRESSION-DRIVEN HBV REACTIVATION AND HAMPERS HBSAG RECOGNITION IN VITRO. Dig. Liver Dis., 47. S. E11 - 3. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1878-3562
Colagrossi, L., Salpini, R., Surdo, M., Battisti, A., Pollicita, M., Bertoli, A., Di Santo, F., Becker, C., Mastroianni, C., Marignani, M., Maylin, S., Delaugerre, C., Morisco, F., Coppola, N., Marrone, A., Sarmati, L., Andreoni, M., Angelico, M., Verheyen, J., Perno, C. F. and Svicher, V. (2015). A HYPER-GLYCOSYLATION OF HBV SURFACE MAJOR HYDROPHILIC REGION CORRELATES WITH IMMUNOSUPPRESSION-DRIVEN HBV REACTIVATION AND HAMPERS HBSAG RECOGNITION IN VITRO. Dig. Liver Dis., 47. S. E11 - 3. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1878-3562
2014
Scheffler, M., Gardizi, M., Bos, M., Koenig, K., Michels, S., Fassunke, J., Heydt, C., Kuenstlinger, H., Ihle, M. A., Ueckeroth, F., Albus, K., Serke, M., Gerigk, U., Schulte, W., Toepelt, K., Nogova, L., Zander, T., Engel-Riedel, W., Stoelben, E., Ko, Y. -D., Randerath, W. J., Kaminsky, B., Panse, J., Becker, C., Hellmich, M., Merkelbach-Bruse, S., Buettner, R., Heukamp, L. C. and Wolf, J. (2014). Genetic heterogeneity and lack of prognostic impact of patients with non-small cell lung cancer (NSCLC) harboring PIK3CA mutation. Oncol. Res. Treat., 37. S. 65 - 66. BASEL: KARGER. ISSN 2296-5262